IAG’s partnering team joins LSX Nordic Congress, Copenhagen, Denmark, 10-11 October 2023
IAG’s partnering team is delighted to announce their participation in the investor-biotech LSX Nordic Congress. The event is scheduled to take place from 10 to 11 October 2023 and will be held at Bella Sky in Copenhagen Denmark.
Olga Kubassova’s inclusion in the lineup of speakers underscores her extensive expertise and thought leadership in the biotech and healthcare sectors. As many biopharma companies have undergone restructuring, reduced their workforce, and streamlined their pipelines, they recalibrate their strategies following the events of 2020 and 2021. This leads investors to shift their focus from purely supporting research initiatives to identifying product prospects with the genuine potential to address significant business opportunities.
The LSX Nordic Congress brings together pharma and industry speakers as well as biotech innovators and experts to explore critical topics, trends, and opportunities in the life sciences and healthcare space. This annual event is renowned for facilitating insightful discussions, networking, and collaboration among key stakeholders in the industry.
During her engagement, Dr. Kubassova will draw upon IAG’s partnering strategy case studies to provide valuable insights into the evolving landscape of biotech investments and healthcare innovations. She will speak about industry trends, investment strategies, and the dynamics shaping the biotech and healthcare sectors.
For more information about the LSX Nordic Congress and to register for the event, please visit the official event website: https://www.lsxleaders.com/lsx-nordic-congress.
Don’t miss this opportunity to hear from Olga Kubassova and other industry leaders who are shaping the future of biotechnology and healthcare at the LSX Nordic Congress.
For media inquiries or to schedule an interview with Olga Kubassova, please contact: olga.kubassova@ia-grp.com